its a third way down on the page from the second link in my post
Alberta
Total investments
$14,900,000
Description of projects
Entos Pharmaceuticals (Edmonton, Alberta)
Entos Pharmaceuticals
-
October 23, 2020: $5.0 million through NRC‑IRAP for phase 1 clinical trials of its Covigenix VAX-001 vaccine candidate
Related link:
Providence Therapeutics and Northern RNA Inc. (Calgary, Alberta)
Providence Therapeutics and Northern RNA Inc.
-
January 21, 2021: Up to $5 million through the Next Generation Manufacturing Canada supercluster, to expand their operations in Calgary to design and manufacture COVID-19 vaccines and build a pipeline of mRNA vaccines
-
October 23, 2020: $4.9 million through NRC-IRAP for phase 1 clinical trials of its PTX-COVID19-B mRNA vaccine candidate
Related links:
